Caspase-Dependent HMGB1 Release from Macrophages Participates in Peripheral Neuropathy Caused by Bortezomib, a Proteasome-Inhibiting Chemotherapeutic Agent, in Mice

Caspase-Dependent HMGB1 Release from Macrophages Participates in Peripheral Neuropathy Caused by Bortezomib, a Proteasome-Inhibiting Chemotherapeutic Agent, in Mice

Given the role of macrophage-derived high mobility group box 1 (HMGB1) in chemotherapy-induced peripheral neuropathy (CIPN) caused by paclitaxel, we analyzed the role of HMGB1 and macrophages in the CIPN caused by bortezomib, a proteasome-inhibiting chemotherapeutic agent used for the treatment of m...

Full description

Bibliographic Details
Main Authors: Maho Tsubota, Takaya Miyazaki, Yuya Ikeda, Yusuke Hayashi, Yui Aokiba, Shiori Tomita, Fumiko Sekiguchi, Dengli Wang, Masahiro Nishibori, Atsufumi Kawabata
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cells
Subjects:
bortezomib
high mobility group box 1 (HMGB1)
chemotherapy-induced peripheral neuropathy
macrophage
caspase
apoptosis
Online Access:https://www.mdpi.com/2073-4409/10/10/2550

Internet

https://www.mdpi.com/2073-4409/10/10/2550

Similar Items